THIRD ROCK VENTURES V, L.P. sold 4.1% of their position (276.51K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $11.09M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/11/2026ACC: 0001193125-26-217092
10% Owner
Since Jun 2024
-276.51K
Net shares
Net seller
$11.09M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
276.51K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−271.50K
Price / share
$40.12
Trade value
$10.89M
% of position
4.0%
5/7/2026
6.71M→6.44M
Common Stock
Direct
Shares
−5.02K
Price / share
$40.31
Trade value
$202.26K
% of position
0.1%
5/8/2026
6.44M→6.43M
Total
Net shares
−276.51K
Net value
-$11.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/7/2026 | S · Sale | −271.50K | $40.12 | $10.89M | 4.0% | 6.71M | 6.44M |
| Common Stock Direct | 5/8/2026 | S · Sale | −5.02K | $40.31 | $202.26K | 0.1% | 6.44M | 6.43M |
| Total | −276.51K | -$11.09M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned969.22K
Total
969.22K indirect969.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 969.22K | Indirect |
| Total | 969.22K | 969.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported